[HTML] springer.comFull View

[HTML][HTML] The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma

Y Zhang, X Gao, Y Zhu, D Kadel, H Sun, J Chen… - Journal of Experimental …, 2018 - Springer
Background The application of VEGF signaling inhibitors have been associated with more
invasive or metastatic behavior of cancers including hepatocellular carcinoma (HCC). We …
被引用次数：32 相关文章

The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma.

Y Zhang, X Gao, Y Zhu, D Kadel, H Sun… - … of Experimental & …, 2018 - europepmc.org
Background The application of VEGF signaling inhibitors have been associated with more
invasive or metastatic behavior of cancers including hepatocellular carcinoma (HCC). We …

The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma

Y Zhang, X Gao, Y Zhu, D Kadel, H Sun… - … of Experimental & …, 2018 - go.gale.com
Background The application of VEGF signaling inhibitors have been associated with more
invasive or metastatic behavior of cancers including hepatocellular carcinoma (HCC). We …
[HTML] nih.gov

[HTML][HTML] The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma

Y Zhang, X Gao, Y Zhu, D Kadel, H Sun… - … of Experimental & …, 2018 - ncbi.nlm.nih.gov
Background The application of VEGF signaling inhibitors have been associated with more
invasive or metastatic behavior of cancers including hepatocellular carcinoma (HCC). We …
[HTML] biomedcentral.com

[HTML][HTML] The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma

Y Zhang, X Gao, Y Zhu, D Kadel… - … of Experimental & …, 2018 - jeccr.biomedcentral.com
The application of VEGF signaling inhibitors have been associated with more invasive or
metastatic behavior of cancers including hepatocellular carcinoma (HCC). We explored the …

The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma.

Y Zhang, X Gao, Y Zhu, D Kadel… - … of Experimental & …, 2018 - search.ebscohost.com
Background: The application of VEGF signaling inhibitors have been associated with more
invasive or metastatic behavior of cancers including hepatocellular carcinoma (HCC). We …

The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma

Y Zhang, X Gao, Y Zhu, D Kadel… - … of experimental & …, 2018 - pubmed.ncbi.nlm.nih.gov
Background The application of VEGF signaling inhibitors have been associated with more
invasive or metastatic behavior of cancers including hepatocellular carcinoma (HCC). We …

The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma.

Y Zhang, X Gao, Y Zhu, D Kadel, H Sun… - … of Experimental & …, 2018 - europepmc.org
Background The application of VEGF signaling inhibitors have been associated with more
invasive or metastatic behavior of cancers including hepatocellular carcinoma (HCC). We …
[PDF] biomedcentral.com

[PDF][PDF] The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma

Y Zhang, X Gao, Y Zhu, D Kadel, H Sun, J Chen, Q Luo… - 2018 - jeccr.biomedcentral.com
Background: The application of VEGF signaling inhibitors have been associated with more
invasive or metastatic behavior of cancers including hepatocellular carcinoma (HCC). We …